CRA consultants supported a pharmaceutical company in its successful challenge of an ANDA filed by a generic manufacturer. The generic company sought to manufacture and sell generic versions of two related diabetes treatments. CRA provided a report analyzing evidence of commercial success for the branded pharmaceutical products as well as deposition and trial testimony.
CRA recognized in Lexology Index: IP
We are delighted to share that Alisa Knapp, Chris Bakewell, Dan McGavock, Dave Duski, Erin Crockett, Greg Bell, Jim Donohue, Julia Rowe, Kim Schenk, Mike Tate,...